Suchergebnisse - "Eichhorst, Barbara"

1

Neue Therapiekonzepte bei der chronisch-lymphatischen Leukämie

von: Eichhorst, Barbara

2016, in: Der Onkologe

Wird geladen...
2

Management of unfit elderly patients with chronic lymphocytic leukemia

von: Eichhorst, Barbara

2018transfer abstract, in: Enhancement of volcanic eruption in mid-ocean ridge during the last deglaciation: New sedimentary evidence in the middle part of Central Indian Ridge

Wird geladen...
3

New treatment approaches in CLL: Challenges and opportunities in the elderly

von: Eichhorst, Barbara

2016transfer abstract, in: Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection

Wird geladen...
4

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

von: Eichhorst, Barbara

2016, in: The lancet / Oncology

Wird geladen...
5

Chronische lymphatische Leukämie

von: Al-Sawaf, Othman

2020, in: Der Internist

Wird geladen...
6

Aktuelle Therapiestrategien zur chronischen lymphatischen Leukämie

von: Langerbeins, Petra

2019, in: Der Onkologe

Wird geladen...
7

Chronische lymphatische Leukämie

von: Al-Sawaf, Othman

2020, in: Der Onkologe

Wird geladen...
8

72/m mit Zufallsbefund einer Lymphozytose

von: Langerbeins, Petra

2022, in: Der Onkologe

Wird geladen...
9

Chronic lymphocytic leukaemia

von: Hallek, Michael

2018transfer abstract, in: Effects of shape functions on flexural–torsional buckling of fixed circular arches

Wird geladen...
10

Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons

von: Elter, Thomas

2008, in: Current hematologic malignancy reports

Wird geladen...
11

Current strategies to create tailored and risk-adapted therapies for CLL patients

von: Cramer, Paula

2016, in: A review of current proteomics technologies with a survey on their widespread use in reproductive biology investigations

Wird geladen...
12

Extramedullary manifestations of chronic lymphocytic leukaemia are not unusual

von: Cramer, Paula

2014, in: N

Wird geladen...
13

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

von: von Tresckow, Julia

2023, in: Annals of hematology

Wird geladen...
14

TP53 mutation and survival in chronic lymphocytic leukemia

von: Zenz, Thorsten

October 10, 2010, in: Journal of clinical oncology

Wird geladen...
15

Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) : a multicentre, open-label, phase 2 trial

von: Cramer, Paula

26 September 2022, in: The lancet. Haematology

Wird geladen...
16

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

von: Cramer, Paula

2018, in: The lancet / Oncology

Wird geladen...
17

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

von: Stilgenbauer, Stephan

2016, in: My

Wird geladen...
18

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

von: Al-Sawaf, Othman

2020, in: My

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!